Literature DB >> 1514783

Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence.

S M Whelan1, M J Elmore, N J Bodsworth, J K Brehm, T Atkinson, N P Minton.   

Abstract

DNA fragments derived from the Clostridium botulinum type A neurotoxin (BoNT/A) gene (botA) were used in DNA-DNA hybridization reactions to derive a restriction map of the region of the C. botulinum type B strain Danish chromosome encoding botB. As the one probe encoded part of the BoNT/A heavy (H) chain and the other encoded part of the light (L) chain, the position and orientation of botB relative to this map were established. The temperature at which hybridization occurred indicated that a higher degree of DNA homology occurred between the two genes in the H-chain-encoding region. By using the derived restriction map data, a 2.1-kb BglII-XbaI fragment encoding the entire BoNT/B L chain and 108 amino acids of the H chain was cloned and characterized by nucleotide sequencing. A contiguous 1.8-kb XbaI fragment encoding a further 623 amino acids of the H chain was also cloned. The 3' end of the gene was obtained by cloning a 1.6-kb fragment amplified from genomic DNA by inverse polymerase chain reaction. Translation of the nucleotide sequence derived from all three clones demonstrated that BoNT/B was composed of 1,291 amino acids. Comparative alignment of its sequence with all currently characterized BoNTs (A, C, D, and E) and tetanus toxin (TeTx) showed that a wide variation in percent homology occurred dependent on which component of the dichain was compared. Thus, the L chain of BoNT/B exhibits the greatest degree of homology (50% identity) with the TeTx L chain, whereas its H chain is most homologous (48% identity) with the BoNT/A H chain. Overall, the six neurotoxins were shown to be composed of highly conserved amino acid domains interceded with amino acid tracts exhibiting little overall similarity. In total, 68 amino acids of an average of 442 are absolutely conserved between L chains and 110 of 845 amino acids are conserved between H chains. Conservation of Trp residues (one in the L chain and nine in the H chain) was particularly striking. The most divergent region corresponds to the extreme carboxy terminus of each toxin, which may reflect differences in specificity of binding to neurone acceptor sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1514783      PMCID: PMC195785          DOI: 10.1128/aem.58.8.2345-2354.1992

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  41 in total

1.  A universal method for the direct cloning of PCR amplified nucleic acid.

Authors:  D A Mead; N K Pey; C Herrnstadt; R A Marcil; L M Smith
Journal:  Biotechnology (N Y)       Date:  1991-07

2.  Nucleotide sequence of the gene encoding Clostridium botulinum neurotoxin type D.

Authors:  T Binz; H Kurazono; M R Popoff; M W Eklund; G Sakaguchi; S Kozaki; K Krieglstein; A Henschen; D M Gill; H Niemann
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

3.  Nucleotide sequence of Clostridium botulinum C1 neurotoxin.

Authors:  D Hauser; M W Eklund; H Kurazono; T Binz; H Niemann; D M Gill; P Boquet; M R Popoff
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

Review 4.  Structure and biological activity of botulinum neurotoxin.

Authors:  B R DasGupta
Journal:  J Physiol (Paris)       Date:  1990

5.  The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene.

Authors:  D E Thompson; J K Brehm; J D Oultram; T J Swinfield; C C Shone; T Atkinson; J Melling; N P Minton
Journal:  Eur J Biochem       Date:  1990-04-20

6.  Heterologous combinations of heavy and light chains from botulinum neurotoxin A and tetanus toxin inhibit neurotransmitter release in Aplysia.

Authors:  B Poulain; S Mochida; U Weller; B Högy; E Habermann; J D Wadsworth; C C Shone; J O Dolly; L Tauc
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

7.  The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins.

Authors:  T Binz; H Kurazono; M Wille; J Frevert; K Wernars; H Niemann
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

8.  The complete amino acid sequence of the Clostridium botulinum type-E neurotoxin, derived by nucleotide-sequence analysis of the encoding gene.

Authors:  S M Whelan; M J Elmore; N J Bodsworth; T Atkinson; N P Minton
Journal:  Eur J Biochem       Date:  1992-03-01

9.  Botulinum neurotoxin type B (strain 657): partial sequence and similarity with tetanus toxin.

Authors:  B R Dasgupta; A Datta
Journal:  Biochimie       Date:  1988-06       Impact factor: 4.079

10.  Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of the constituent chains.

Authors:  B Poulain; S Mochida; J D Wadsworth; U Weller; E Habermann; J O Dolly; L Tauc
Journal:  J Physiol (Paris)       Date:  1990
View more
  32 in total

1.  Purification of fully activated Clostridium botulinum serotype B toxin for treatment of patients with dystonia.

Authors:  Hideyuki Arimitsu; Kaoru Inoue; Yoshihiko Sakaguchi; Jaechul Lee; Yukako Fujinaga; Toshihiro Watanabe; Tohru Ohyama; Robert Hirst; Keiji Oguma
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.

Authors:  K K Hill; T J Smith; C H Helma; L O Ticknor; B T Foley; R T Svensson; J L Brown; E A Johnson; L A Smith; R T Okinaka; P J Jackson; J D Marks
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

3.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.

Authors:  R Zichel; A Mimran; A Keren; A Barnea; I Steinberger-Levy; D Marcus; A Turgeman; S Reuveny
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

5.  Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan.

Authors:  Kaoru Umeda; Yoshiyuki Seto; Tomoko Kohda; Masafumi Mukamoto; Shunji Kozaki
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

6.  Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species.

Authors:  M Z Atassi; B Z Dolimbek; M Hayakari; J L Middlebrook; B Whitney; M Oshima
Journal:  J Protein Chem       Date:  1996-10

7.  Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material.

Authors:  M Lindström; R Keto; A Markkula; M Nevas; S Hielm; H Korkeala
Journal:  Appl Environ Microbiol       Date:  2001-12       Impact factor: 4.792

8.  Physicochemical and immunological characterization of the type E botulinum neurotoxin binding protein purified from Clostridium botulinum.

Authors:  B R Singh; J Foley; C Lafontaine
Journal:  J Protein Chem       Date:  1995-01

9.  Detection of the genes encoding botulinum neurotoxin types A to E by the polymerase chain reaction.

Authors:  E A Szabo; J M Pemberton; P M Desmarchelier
Journal:  Appl Environ Microbiol       Date:  1993-09       Impact factor: 4.792

10.  Gene probes for identification of the botulinal neurotoxin gene and specific identification of neurotoxin types B, E, and F.

Authors:  K D Campbell; M D Collins; A K East
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.